Free Trial

Oncology Institute (TOI) Competitors

Oncology Institute logo
$0.55 +0.07 (+13.40%)
As of 01/17/2025 04:00 PM Eastern

TOI vs. PIII, BNR, XGN, ENZ, CCM, PMD, MRAI, ATIP, BRTX, and KDLY

Should you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include P3 Health Partners (PIII), Burning Rock Biotech (BNR), Exagen (XGN), Enzo Biochem (ENZ), Concord Medical Services (CCM), Psychemedics (PMD), Marpai (MRAI), ATI Physical Therapy (ATIP), BioRestorative Therapies (BRTX), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry.

Oncology Institute vs.

Oncology Institute (NASDAQ:TOI) and P3 Health Partners (NASDAQ:PIII) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, community ranking, dividends and risk.

Oncology Institute currently has a consensus price target of $2.50, suggesting a potential upside of 354.55%. P3 Health Partners has a consensus price target of $2.38, suggesting a potential upside of 1,052.91%. Given P3 Health Partners' higher probable upside, analysts clearly believe P3 Health Partners is more favorable than Oncology Institute.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oncology Institute
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
P3 Health Partners
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

P3 Health Partners has higher revenue and earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than P3 Health Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oncology Institute$324.24M0.13-$83.07M-$0.78-0.71
P3 Health Partners$1.27B0.06-$57.77M-$0.84-0.25

36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are owned by institutional investors. 9.5% of Oncology Institute shares are owned by company insiders. Comparatively, 17.9% of P3 Health Partners shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

P3 Health Partners has a net margin of -6.95% compared to Oncology Institute's net margin of -17.63%. P3 Health Partners' return on equity of -71.31% beat Oncology Institute's return on equity.

Company Net Margins Return on Equity Return on Assets
Oncology Institute-17.63% -186.83% -34.58%
P3 Health Partners -6.95%-71.31%-11.93%

Oncology Institute has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.

Oncology Institute and P3 Health Partners both received 4 outperform votes by MarketBeat users. However, 66.67% of users gave Oncology Institute an outperform vote while only 26.67% of users gave P3 Health Partners an outperform vote.

CompanyUnderperformOutperform
Oncology InstituteOutperform Votes
4
66.67%
Underperform Votes
2
33.33%
P3 Health PartnersOutperform Votes
4
26.67%
Underperform Votes
11
73.33%

In the previous week, P3 Health Partners' average media sentiment score of -0.75 beat Oncology Institute's score of -0.86 indicating that P3 Health Partners is being referred to more favorably in the news media.

Company Overall Sentiment
Oncology Institute Negative
P3 Health Partners Negative

Summary

P3 Health Partners beats Oncology Institute on 11 of the 16 factors compared between the two stocks.

Get Oncology Institute News Delivered to You Automatically

Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TOI vs. The Competition

MetricOncology InstituteOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$41.56M$1.17B$5.21B$9.14B
Dividend YieldN/AN/A5.13%4.02%
P/E Ratio-0.7112.6489.3417.36
Price / Sales0.131.621,240.0477.11
Price / CashN/A40.2443.7535.97
Price / Book0.717.945.314.79
Net Income-$83.07M-$52.07M$122.54M$225.00M
7 Day Performance76.45%12.42%0.59%2.62%
1 Month Performance161.78%18.99%2.55%3.81%
1 Year Performance-74.30%-8.35%25.29%20.10%

Oncology Institute Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TOI
Oncology Institute
2.4781 of 5 stars
$0.55
+13.4%
$2.50
+354.5%
-74.3%$41.56M$324.24M-0.71660Gap Up
High Trading Volume
PIII
P3 Health Partners
2.3988 of 5 stars
$0.21
-0.1%
$2.38
+1,005.2%
-83.0%$77.11M$1.48B-0.26500Positive News
Gap Up
High Trading Volume
BNR
Burning Rock Biotech
2.095 of 5 stars
$6.55
-6.7%
N/A-29.7%$67.10M$510.89M-2.181,390Short Interest ↓
Positive News
High Trading Volume
XGN
Exagen
4.7657 of 5 stars
$3.12
-1.6%
$7.50
+140.4%
+101.5%$55.03M$55.75M-3.32220
ENZ
Enzo Biochem
1.6871 of 5 stars
$0.66
-3.4%
N/A-51.8%$34.32M$30.31M0.00520Analyst Forecast
Gap Up
CCM
Concord Medical Services
0.776 of 5 stars
$4.51
-2.4%
N/A-53.2%$19.58M$471.70M0.00970Analyst Forecast
Gap Down
PMD
Psychemedics
N/A$2.67
-1.8%
N/A-20.1%$15.73M$22.10M-5.24140Positive News
Gap Down
High Trading Volume
MRAI
Marpai
N/A$1.00
+3.1%
$6.00
+500.0%
-12.1%$13.74M$34.87M-0.38150
ATIP
ATI Physical Therapy
N/A$2.63
+0.4%
N/A-80.3%$11.60M$741.86M-0.145,600High Trading Volume
BRTX
BioRestorative Therapies
3.9437 of 5 stars
$1.56
-4.3%
$18.00
+1,053.8%
+25.5%$10.80M$377,000.00-1.027Positive News
Gap Up
KDLY
Kindly MD
N/A$1.44
+0.8%
N/AN/A$8.62M$2.88M0.00N/APositive News
Gap Down

Related Companies and Tools


This page (NASDAQ:TOI) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners